A metagenomic-based precision-medicine tool for personalized diagnosis, prognosi...
A metagenomic-based precision-medicine tool for personalized diagnosis, prognosis and treatment of oral diseases
About 20M dental implants are performed globally per year. Implant market, valued at €3.6B in 2020, is growing at a CAGR of 11%. Unfortunately, microbiome-biofilm-associated diseases can affect dental implants, compromising oral a...
About 20M dental implants are performed globally per year. Implant market, valued at €3.6B in 2020, is growing at a CAGR of 11%. Unfortunately, microbiome-biofilm-associated diseases can affect dental implants, compromising oral and systemic health. More than 50% of implant patients develop mucositis, an inflammation of the soft tissues, which may lead to peri-implantitis, a severe infection affecting soft and hard tissues that can lead to implant loss. Currently, there are no reliable tools to assess disease severity and risk of disease progression; and the dentist can only prescribe empirical therapies without knowing the composition of the triggering peri-implant plaque microbiome. At PreBiomics, we developed a precision-medicine test that characterises the microbial composition of the plaque biofilm collected in the area surrounding the implant. In 10 years of research, we have shown that specific bacteria's presence is key to predicting the infection's severity and progression. PreBiomicsPMT will develop a test using metagenomics, and an AI algorithm, which will enable the implementation of monitoring and diagnosis and provide treatment recommendations for each patient based on the bacterial composition of their plaque microbiome. Based on the results of the ERC POCs PB3P, this EIC-Transition project aims at automating the workflow using a robotic solution to reduce the costs of the service and speed up the results, building an extensive database that will be used to create an antibiotic resistance panel and further develop our decision support system (DSS) for dentists, finally, conducting a validation study to prove the predictive power of our DSS. Alongside the technical development, we will define the IPR management plan to protect the knowledge we continuously generate, study in-depth the dental implants market and the needs and expectations of our customers and investors and elaborate a robust business plan to allow proper exploitation of our product.ver más
02-11-2024:
Generación Fotovolt...
Se ha cerrado la línea de ayuda pública: Subvenciones destinadas al fomento de la generación fotovoltaica en espacios antropizados en Canarias, 2024
01-11-2024:
ENESA
En las últimas 48 horas el Organismo ENESA ha otorgado 6 concesiones
01-11-2024:
FEGA
En las últimas 48 horas el Organismo FEGA ha otorgado 1667 concesiones
Seleccionando "Aceptar todas las cookies" acepta el uso de cookies para ayudarnos a brindarle una mejor experiencia de usuario y para analizar el uso del sitio web. Al hacer clic en "Ajustar tus preferencias" puede elegir qué cookies permitir. Solo las cookies esenciales son necesarias para el correcto funcionamiento de nuestro sitio web y no se pueden rechazar.
Cookie settings
Nuestro sitio web almacena cuatro tipos de cookies. En cualquier momento puede elegir qué cookies acepta y cuáles rechaza. Puede obtener más información sobre qué son las cookies y qué tipos de cookies almacenamos en nuestra Política de cookies.
Son necesarias por razones técnicas. Sin ellas, este sitio web podría no funcionar correctamente.
Son necesarias para una funcionalidad específica en el sitio web. Sin ellos, algunas características pueden estar deshabilitadas.
Nos permite analizar el uso del sitio web y mejorar la experiencia del visitante.
Nos permite personalizar su experiencia y enviarle contenido y ofertas relevantes, en este sitio web y en otros sitios web.